Biosimilars Communication Pharmacy Management 
Pharmacy Times
AUGUST 7, 2025
SHOW MORE The FDA intends to update opioid labels to highlight risks of addiction, overdose, and interactions, enhancing safety in pain management practices. 4 By integrating FDA's new labeling requirements and CDC's framework into daily practice, pharmacists can significantly lessen opioid risk. REFERENCES 1.
Pharmacy Times
JUNE 13, 2025
CPAs are essentially signed contracts that have formal agreements with well-defined scopes, which allow for collaboration and communication among health care professionals in areas lacking aspects of health care, according to Klepser. This is where collaborative practice agreements (CPAs) come in.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
JULY 24, 2025
Yet, despite growing awareness, HFpEF remains difficult to manage due to nonspecific symptoms, limited clinical trial data, and inconsistencies in diagnosis. As several pharmacists explained, the challenge often begins with identifying who has HFpEF. The FDA’s Prescription Drug User Fee Act date for finerenone is in July 2025.
Pharmacy Times
JUNE 11, 2025
The findings highlight that there remain communication gaps between oncology providers and patients and that opportunities exist for pharmacists to counsel newly diagnosed oncology patients on their fertility preservation options.
Pharmacy Times
JULY 28, 2025
Communicating with vaccine-hesitant parents: a narrative review. Trust, influence, and community: why pharmacists and pharmacies are central for addressing vaccine hesitancy. Causes of vaccine hesitancy in adults for the influenza and COVID-19 vaccines: a systematic literature review. Vaccines (Basel). 2022;10(9):1518.
Pharmacy Times
JUNE 17, 2025
If a discrepancy is found, the pharmacy nurses will hold the shipment, and a clinical intervention will be communicated to the provider. Results American Oncology Network (AON) Pharmacy collected data on waste and cost avoidance from February 2023 to September 2023.
Pharmacy Times
JUNE 20, 2025
For effective patient care, we need smart people to design workflows for operationalizing 505(b)(2) drugs, integrating the next biosimilar we have to stock, and managing the compounding of a new hazardous drug. We need people to coordinate and track prior authorizations, write persuasive appeal letters, and keep patients updated.
Expert insights. Personalized for you.
Let's personalize your content